Temitayo Omowumi Alegbejo Price

Mrs. Temitayo Omowumi Alegbejo Price

Universidade de São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in ACS Omega
Verified
Journal Article
Open access
VRVerónica Ramírez-Cid
Verónica Ramírez-Cid
ACAna Luisa Chávez-Hernández
Ana Luisa Chávez-Hernández
OLOsvaldo Sánchez López
Osvaldo Sánchez López
RNRaul Marques Novais
Raul Marques Novais
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
JMJose Medina-Franco
Jose Medina-Franco
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with those of synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated collection of open natural product (COCONUT) data set with more than 695,133 unique (nonduplicate) natural products and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage, and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1214 fragments based on distinct heterocyclic scaffolds and natural product-derived chemicals. The fragment libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.

11 January 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
THTomas Horsten
Tomas Horsten
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
LMLuc Van Meervelt
Luc Van Meervelt
FEFlavio Emery
Flavio Emery
Wim DehaenWim Dehaen
Wim Dehaen
Herein, a metal-free methodology towards 2-imidazolidinone benzofurans via piperazinone enaminoesters addition onto quinones and subsequent rearrangement has been disclosed.

18 October 2022 in Organics
Verified
Journal Article
Open access
PDF file
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
FEFlavio Emery
Flavio Emery
Wim DehaenWim Dehaen
Wim Dehaen
Pyrido[3,4-c]pyridazines are nitrogen-containing scaffolds that have been described as being promising in medicinal chemistry, but they are rather rare chemicals. In this review article, the literature on synthetic pathways towards pyrido[3,4-c]pyridazines is listed exhaustively, first with the bicyclic systems themselves that are obtained starting either from pyridines, pyridazines or other heterocycles. Then, the reports on the related tricyclic derivatives are discussed, again according to the source heterocycle, and finally we mention some examples on polycyclic systems.

14 July 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
TFThamires Froes
Thamires Froes
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
BGBruna Fleck Godoi
Bruna Fleck Godoi
MVMiguel Menezes Vaidergorn
Miguel Menezes Vaidergorn
TSThiago dos Santos
Thiago dos Santos
MNMaria Cristina Nonato
Maria Cristina Nonato
Covalent drug design applied to parasite proteins enables selective therapies by targeting nucleophilic residues of macromolecules. We present the first covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (LbDHODH), a key enzyme in pyrimidine biosynthesis with a reactive cysteine (Cys131) in its active site. From barbituric acid derivatives, we discovered 2i as a LbDHODH inhibitor with leishmanicidal activity, exhibiting an IC50 of 0.5 ± 0.1 μM, a Kinact/KI of 767 M-1s-1, no inhibition of the human ortholog, and an EC50 of 11 ± 5 μM in L. braziliensis promastigotes, with no cytotoxicity in THP-1 cells and good passive permeability. X-ray crystallography confirms covalent bond formation with Cys131 and reveals active-site rearrangements. These findings support the proposed covalent inhibition mechanism and provide structural insights for further optimization. Our study validates LbDHODH as a promising target for leishmaniasis therapy and highlights the potential of covalent inhibition in antiparasitic drug discovery.

26 May 2026 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Open access
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
DSDaniel G. Silva
Daniel G. Silva
MVMiguel M. Vaidergorn
Miguel M. Vaidergorn
BABeatriz S. Augusto
Beatriz S. Augusto
AMAn Matheeussen
An Matheeussen
FEFlavio Emery
Flavio Emery
Neglected tropical diseases such as Chagas disease remain poorly served by current chemotherapies due to toxicity and the emergence of drug resistance. Nitroaromatic compounds represent an established antitrypanosomal strategy, relying on bioactivation by Trypanosoma type I nitroreductases. In this study, a fragment-based design approach was applied to the nitroaromatic drugs nifurtimox and benznidazole to generate a novel hybrid scaffold, (E)-N-benzyl-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (1). A series of twenty-two analogues was synthesized by modifying the benzylamine substituent and evaluated for antitrypanosomal activity and susceptibility to nitroreductase I-mediated activation and early ADME properties. Among the series, (E)-N-(4-methylbenzyl)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (3) and (1) exhibited potent anti-T. cruzi activity (0.14 μM and 0.23 μM), anti-T. b. brucei activity (0.59 ± 0.03 μM and 29.3 ± 15.6 μM), and anti-T. b. rhodesiense (0.87 ± 0.8 μM and 7.44 ± 1.00 μM) in parasite cultures. These findings identify this chemotype as a promising starting point for the further development of nitroreductase-activated therapeutics for Trypanosomiasis disease.

6 February 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
VRVerónica Ramírez-Cid
Verónica Ramírez-Cid
ACAna Luisa Chávez-Hernández
Ana Luisa Chávez-Hernández
OLOsvaldo Sánchez López
Osvaldo Sánchez López
RNRaul Marques Novais
Raul Marques Novais
TPTemitayo Omowumi Alegbejo Price
Temitayo Omowumi Alegbejo Price
JMJose Medina-Franco
Jose Medina-Franco
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated Collection of Open Natural Products (COCONUT) data set with more than 695,133 non-redundant natural products, and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1,214 fragments based on novel heterocyclic scaffolds and natural product-derived chemicals. The fragments libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.